Search

Work at the Max Planck Institute of Molecular Physiology has revealed a welcome surprise: a potential new class of COVID-19 drugs.

DFE Pharma’s Korinde Van Den Heuvel talks to us about what made her company’s new 3D printed tablets possible, and which ills they can cure.

Sitting Down With… Evelina Vågesjö, Chief Executive Officer at Ilya Pharma, Sweden.

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

Mike Rea of IDEA Pharma shares his thoughts on what players in pharma positioning are getting right – and wrong.

Emerging technologies are proving that small molecules aren't yesterday's news.

A pill developed at MIT and inspired by tortoises could replace injections for monoclonal antibody therapies.

How is the field of antibody drug conjugates being reshaped?

Though mRNA technologies are helping to expand the industry's horizons, there manufacture does come with challenges.

How can logistics companies meet the evolving needs of global clients while maintaining resilience over the long-term?